Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: A randomized controlled study

被引:214
作者
Dogra, GK
Herson, H
Hutchison, B
Irish, AB
Heath, CH
Golledge, C
Luxton, G
Moody, H
机构
[1] Univ Western Australia, Dept Med, Perth, WA 6009, Australia
[2] Sir Charles Gairdner Hosp, Dept Microbiol, Perth, WA, Australia
[3] Royal Perth Hosp, Dept Microbiol, Perth, WA 6847, Australia
[4] Royal Perth Hosp, Dept Nephrol, Perth, WA 6847, Australia
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 08期
关键词
D O I
10.1097/01.ASN.0000022890.29656.22
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Tunneled catheters are widely used for the provision of hemodialysis. Long-term catheter survival is limited by tunneled catheter-related infections (CRI). This study assesses the efficacy of catheter-restricted filling with gentamicin and citrate in preventing CRI in hemodialysis patients. A double-blind randomized study was conducted to compare heparin (5000 U/ml) with gentamicin/citrate (40 mg/ml and 3.13% citrate; ratio 2:1) as catheter-lock solutions. A total of 112 tunneled catheters in 83 patients were enrolled at the time of catheter insertion for commencement or maintenance of hemodialysis. The primary end point was CRI. Catheter malfunction, defined as blood flow rate of <200 ml/min for three consecutive dialyses and/or the use of urokinase, was also assessed as a secondary end point. Infection rates per 100 catheter-days were 0.03 in the gentamicin group versus 0.42 in the heparin group (P = 0.003). Kaplan-Meier survival analyses showed mean infection-free catheter survival of 282 d (95% CI, 272 to 293 d) in the gentamicin group versus 181 d (95% CI, 124 to 237 d) in the heparin group (log rank, 9.58; P = 0.002). Cox regression analyses showed a relative risk for infection-free catheter survival of 0.10 (95% CI, 0.01 to 0.92) in the gentarnicin group when adjusted for gender, race, diabetes mellitus, catheter malfunction, and hemoglobin (P = 0.042). The incidence of catheter malfunction was not significantly different between groups. Predialysis gentamicin levels were significantly higher in patients randomized to gentamicin (gentamicin/citrate: median 2.8 mg/L [range, 0.6 to 3.5 mg/L], n = 5; heparin: median <0.2 mg/L [range <0.2 to 0.2 mg/L], n = 5; P = 0.008). Tunneled hemodialysis catheter-restricted filling with gentamicin and citrate is a highly effective strategy for prevention of CRI. Although citrate as a catheter-lock solution provides adequate anticoagulation for the interdialytic period, gentamicin levels suggest significant risk for chronic aminoglycoside exposure and associated ototoxicity. Before this technique is adopted, these preliminary observations warrant replication in future studies that will examine the efficacy and safety of lower doses of gentarnicin or alternative agents with a reduced potential for toxicity.
引用
收藏
页码:2133 / 2139
页数:7
相关论文
共 22 条
[1]  
Ajjarapu S, 1999, APPL ENVIRON MICROB, V65, P5394
[2]  
Ash Stephen R., 1999, Journal of the American Society of Nephrology, V10, p272A
[3]  
BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235
[4]   EFFICACY OF 1.4 PERCENT SODIUM-CITRATE IN MAINTAINING ARTERIAL CATHETER PATENCY IN PATIENTS IN A MEDICAL ICU [J].
BRANSON, PK ;
MCCOY, RA ;
PHILLIPS, BA ;
CLIFTON, GD .
CHEST, 1993, 103 (03) :882-885
[5]   Filling hemodialysis catheters in the interdialytic period: Heparin versus citrate versus polygeline: A prospective randomized study [J].
Buturovic, J ;
Ponikvar, R ;
Kandus, A ;
Boh, M ;
Klinkmann, J ;
Ivanovich, P .
ARTIFICIAL ORGANS, 1998, 22 (11) :945-947
[6]   Haemodialysis catheter-related infection: time for action [J].
Canaud, B .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (10) :2288-2290
[7]   LABORATORY DIAGNOSIS OF INTRAVASCULAR CATHETER ASSOCIATED SEPSIS [J].
COLLIGNON, PJ ;
MUNRO, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (09) :807-814
[8]  
Cooper Randy I., 1999, Journal of the American Society of Nephrology, V10, p203A
[9]   The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease [J].
Foley, RN ;
Parfrey, PS ;
Harnett, JD ;
Kent, GM ;
Murray, DC ;
Barre, PE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (01) :53-61
[10]   Prevention of intravascular catheter-related infections [J].
Mermel, LA .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (05) :391-402